ACM Global Central Laboratory has launched an enhanced version of its proprietary Labstar system, which captures all clinical trial testing data in one location to facilitate access and reporting.
The upgraded system is now completely compliant with the CDISC laboratory model, which saves considerable time and effort by standardising the data-capture format.
Labstar features an auto-convert function that allows users to toggle between the conventional and standard-interface units of report formats as required.
The web-based platform is available on a global basis and only requires an internet connection.
Access is secure and compliant with FDA regulations, requiring proper login information for authorised individuals.
Users can schedule automatic reports and receive alerts in their email when the reports are accessible.
Per-subject reports are available for trial investigators and per-study reports offer sponsor analysis on enrolment status, test result trending and summary data, among many other variables.
Labstar's ad-hoc reporting enables users to analyse data by any result - demographic or therapeutic detail.
Labstar data is in accordance with GCP and Hippa regulations and now enables feedback to ACM for training requests, technical issues or suggestions for continual improvement.
